Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BeOne Medicines Ltd.ONC · Entity 2168 | SVP, General Counsel | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BeOne Medicines Ltd.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-09-30 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-30 · Sale · Disposed 1,115 · Balance 0 F2: Each American Depositary Share represents 13 Ordinary Shares. F3: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 311,324 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 311,324 F1: Includes 507 ordinary shares acquired pursuant to the Company's 2018 Employee Share Purchase Plan, as amended from time to time. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 507 ordinary shares acquired pursuant to the Company's 2018 Employee Share Purchase Plan, as amended from time to time.
F2: Each American Depositary Share represents 13 Ordinary Shares.
F3: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2025 Filed Sep 12, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 23,348 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · derivative · entry 11 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 225,602 Underlying: Ordinary Shares · 23,348 shares Expires 2033-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F7 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 88,426 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · derivative · entry 10 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,550 Underlying: Ordinary Shares · 88,426 shares Expires 2032-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 500 | $327.93 | $163,965.00 |
DisclosureSEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 9 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 300 | $326.80 | $98,040.00 |
DisclosureSEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 8 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 500 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 3,318 | $325.73 | $1,080,760.20 |
DisclosureSEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 7 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 800 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.50 to $326.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 4,776 | $325.19 | $1,553,123.68 |
DisclosureSEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 6 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,118 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.49 to $325.48, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 296 | $159.03 | $47,072.88 |
DisclosureSEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 5 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 1,796 | $213.32 | $383,122.72 |
DisclosureSEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 4 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 6,802 | $194.47 | $1,322,784.94 |
DisclosureSEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 3 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 1,112 | $325.00 | $361,400.00 |
DisclosureSEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 50,037 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · derivative · entry 8 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,758 Underlying: Ordinary Shares · 50,037 shares Expires 2034-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F7 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 56,953 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · derivative · entry 7 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 131,976 Underlying: Ordinary Shares · 56,953 shares Expires 2032-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 3,849 | $301.00 | $1,158,552.85 |
DisclosureSEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · nonDerivative · entry 6 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.00 to $301.03, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 6,052 | $300.19 | $1,816,724.46 |
DisclosureSEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · nonDerivative · entry 5 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,178 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 3,849 | $159.03 | $612,106.47 |
DisclosureSEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · nonDerivative · entry 4 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 4,381 | $194.47 | $851,973.07 |
DisclosureSEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · nonDerivative · entry 3 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:38 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 1,112 | $300.00 | $333,600.00 |
DisclosureSEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025. Read SEC document |
| July 30, 2025 Filed Jul 31, 2025 21:04 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 920 | $304.60 | $280,232.74 |
DisclosureSEC source: 0001651308-25-000121 · wk-form4_1753995836.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 29, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.5725 to $304.605, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 21:12 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 422 | $266.50 | $112,463.00 |
DisclosureSEC source: 0001651308-25-000114 · wk-form4_1750281121.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 21:49 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 88,244 | $0.00 Strike: $20.26 | $0.00 |
DisclosureSEC source: 0001651308-25-000109 · wk-form4_1749764963.xml · derivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,244 Underlying: Ordinary Shares · 88,244 shares Expires 2035-06-09 F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 10, 2025 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 21:49 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantOrdinary Shares | 46,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-25-000109 · wk-form4_1749764963.xml · nonDerivative · entry 1 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,920 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 230 | $256.79 | $59,062.67 |
DisclosureSEC source: 0001651308-25-000103 · wk-form4_1749589042.xml · nonDerivative · entry 3 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.4629 to $256.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 470 | $255.78 | $120,217.21 |
DisclosureSEC source: 0001651308-25-000103 · wk-form4_1749589042.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.46 to $256.3911, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| March 05, 2025 Filed Mar 8, 2025 00:20 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 40,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-25-000044 · wk-form4_1741393244.xml · nonDerivative · entry 1 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,142 F1 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:49 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,205 | $275.00 | $331,375.00 |
DisclosureSEC source: 0001651308-25-000037 · wk-form4_1741038558.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2023, as most recently amended on February 28, 2024. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 22:04 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 100 | $260.22 | $26,021.50 |
DisclosureSEC source: 0001651308-25-000020 · wk-form4_1740521076.xml · nonDerivative · entry 4 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2023, as most recently amended on February 28, 2024. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 22:04 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 598 | $258.69 | $154,699.25 |
DisclosureSEC source: 0001651308-25-000020 · wk-form4_1740521076.xml · nonDerivative · entry 3 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2023, as most recently amended on February 28, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.48 to $259.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 22:04 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 504 | $256.84 | $129,448.97 |
DisclosureSEC source: 0001651308-25-000020 · wk-form4_1740521076.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 698 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2023, as most recently amended on February 28, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.74 to $257.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 23:13 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,202 | $237.10 | $284,994.20 |
DisclosureSEC source: 0001651308-24-000127 · wk-form4_1727910822.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2023, as most recently amended on February 28, 2024. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 21:06 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 834 | $160.57 | $133,915.38 |
DisclosureSEC source: 0001651308-24-000092 · wk-form4_1722546357.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 29, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 21:24 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 129 | $159.74 | $20,605.85 |
DisclosureSEC source: 0001651308-24-000071 · wk-form4_1718918661.xml · nonDerivative · entry 4 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.40 to $160.33, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 21:24 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 208 | $159.68 | $33,213.23 |
DisclosureSEC source: 0001651308-24-000071 · wk-form4_1718918661.xml · nonDerivative · entry 3 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.12 to $159.89, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 21:24 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 102 | $158.20 | $16,135.93 |
DisclosureSEC source: 0001651308-24-000071 · wk-form4_1718918661.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 337 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.10 to $159.05, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:03 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 184,795 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001651308-24-000066 · wk-form4_1717794184.xml · derivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,795 Underlying: Ordinary Shares · 184,795 shares Expires 2034-06-04 F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:03 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 98,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-24-000066 · wk-form4_1717794184.xml · nonDerivative · entry 1 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,399 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 21:10 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 791 | $216.26 | $171,059.05 |
DisclosureSEC source: 0001651308-23-000128 · wf-form4_169101062121566.xml · nonDerivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 29, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.068 to $216.2962, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 22:55 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 248,950 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001651308-23-000093 · wf-form4_168730171982754.xml · derivative · entry 2 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,950 Underlying: Ordinary Shares · 248,950 shares Expires 2033-06-14 F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 22:55 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 65,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-23-000093 · wf-form4_168730171982754.xml · nonDerivative · entry 1 Lee Chan Henry · CIK 0001980648 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,597 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.